12-118079419-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_019086.6(VSIG10):c.852T>A(p.Asp284Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000626 in 1,613,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_019086.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VSIG10 | NM_019086.6 | c.852T>A | p.Asp284Glu | missense_variant | 4/9 | ENST00000359236.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VSIG10 | ENST00000359236.10 | c.852T>A | p.Asp284Glu | missense_variant | 4/9 | 1 | NM_019086.6 | P1 | |
VSIG10 | ENST00000538357.1 | c.549T>A | p.Asp183Glu | missense_variant | 3/3 | 2 | |||
VSIG10 | ENST00000545722.1 | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152148Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000642 AC: 16AN: 249240Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135220
GnomAD4 exome AF: 0.0000623 AC: 91AN: 1461708Hom.: 0 Cov.: 31 AF XY: 0.0000605 AC XY: 44AN XY: 727136
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 07, 2022 | The c.852T>A (p.D284E) alteration is located in exon 4 (coding exon 4) of the VSIG10 gene. This alteration results from a T to A substitution at nucleotide position 852, causing the aspartic acid (D) at amino acid position 284 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at